GI
NEO icon

GAMMA Investing’s NeoGenomics NEO Stock Holding History

GAMMA Investing’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Sell
2,138
-409
-16% -$3.95K ﹤0.01% 2593
2026
Q1 		$18.9K Sell
2,547
-1,055
-29% -$11.1K ﹤0.01% 2743
2025
Q4 		$42.4K Buy
3,602
+1,460
+68% +$15.8K ﹤0.01% 2179
2025
Q3 		$16.5K Buy
2,142
+81
+4% +$567 ﹤0.01% 2615
2025
Q2 		$15.1K Buy
2,061
+189
+10% +$1.52K ﹤0.01% 2607
2025
Q1 		$17.8K Buy
1,872
+401
+27% +$5.01K ﹤0.01% 2456
2024
Q4 		$24.2K Buy
1,471
+114
+8% +$1.77K ﹤0.01% 2162
2024
Q3 		$20K Buy
1,357
+678
+100% +$10.6K ﹤0.01% 2110
2024
Q2 		$9.42K Sell
679
-371
-35% -$5.26K ﹤0.01% 2282
2024
Q1 		$16.5K Sell
1,050
-431
-29% -$6.66K ﹤0.01% 1773
2023
Q4 		$22K Buy
+1,481
New +$24.2K 0.01% 1433

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

GAMMA Investing's NEO Position: Q2 2026 in Review

GAMMA Investing reduced its NeoGenomics (NEO) stake by 16% in Q2 2026, selling an estimated $3.95K and leaving 2,138 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2593.

GAMMA Investing first reported a position in NEO in Q4 2023 and has held it in 11 quarters since. The position peaked at $42.4K in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • GAMMA Investing held 2,138 shares of NeoGenomics worth $31.2K as of Q2 2026.
  • GAMMA Investing sold 409 NeoGenomics shares in Q2 2026, an estimated $3.95K.
  • NeoGenomics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2593 holding.
  • GAMMA Investing first reported a position in NeoGenomics in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's NeoGenomics position peaked at $42.4K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.